1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
89
2f
1d
2 29
1d
25
2f
Susan Matesanz, MD
4eAssistant Professor of Clinical Neurology
28
73
3
60
Attending Physician, The Children's Hospital of Philadelphia
6c
Medical Director, Clinical In Vivo Gene Therapy, CHOP
11
Department: Neurology
4
1
b
1d
46
Contact information
5f
4
3
3
3
2
4
b
1f
5f
3401 Civic Center Blvd
Philadelphia, PA 19146
26
Philadelphia, PA 19146
35
f
13
Education:
21 7 BA 2e (Psychology and Spanish Literature) c
2a Dartmouth College, 2008.
21 7 MD c
39 Johns Hopkins School of Medicine, 2014.
c
3
3
21
21 7 BA 2e (Psychology and Spanish Literature) c
2a Dartmouth College, 2008.
21 7 MD c
39 Johns Hopkins School of Medicine, 2014.
c
1f
Post-Graduate Training
24 56 Pediatric Residency, Children's Hospital of Philadelphia, 2014-2016.
24 60 Child Neurology Residency, The Children's Hospital of Philadelphia, 2016-2019.
24 69 Pediatric Neuromuscular Fellowship, The Children's Hospital of Philadelphia, 2019-2020.
c
3
25
24 56 Pediatric Residency, Children's Hospital of Philadelphia, 2014-2016.
24 60 Child Neurology Residency, The Children's Hospital of Philadelphia, 2016-2019.
24 69 Pediatric Neuromuscular Fellowship, The Children's Hospital of Philadelphia, 2019-2020.
c
17
Certifications
28 7c Neurology with Special Qualification in Child Neurology, American Board of Psychiatry and Neurology, 2019.
28 45 American Board of Electrodiagnostic Medicine, 2021.
c
3
8d
Permanent link28 7c Neurology with Special Qualification in Child Neurology, American Board of Psychiatry and Neurology, 2019.
28 45 American Board of Electrodiagnostic Medicine, 2021.
c
2 29
21
1e
1d
24
2b
29
27
23
1fe Byrne BJ, Flanigan KM, Matesanz SE, Finkel RS, Waldrop MA, D'Ambrosio ES, Johnson NE, Smith BK, Bönnemann C, Carrig S, Rossano JW, Greenberg B, Lalaguna L, Lara-Pezzi E, Subramony S, Corti M, Mercado-Rodriguez C, Leon-Astudillo C, Ahrens-Nicklas R, Bharucha-Goebel D, Gao G, Gessler DJ, Hwu WL, Chien YH, Lee NC, Boye SL, Boye SE, George LA.: Current clinical applications of AAV-mediated gene therapy. Mol Ther 33: 2479-2516, Jun 2025.
e2 Fainberg NA, Keselman D, Matesanz SE, Senthil K.: Feeding Difficulties and Respiratory Failure in a 14-Month-Old Girl. Pediatr Rev 46: 337-340, Jun 2025.
11c Wadhwani AR, Aggarwal A, Loscalzao S, McSherry ML, Lockman JL, Brandsema JF, McGuire J, Matesanz S.: Pearls & Oy-sters: Severe Myotonic Crisis Resembling Malignant Hyperthermia. Neurology 104: e213497, Apr 2025.
139 Keselman D, Glanzman A, Thelen MY, Prosser LA, McGuire J, Matesanz SE.: Motor function testing rates and outcomes in Duchenne muscular dystrophy with comorbid autism and attention-deficit/hyperactivity disorder. Neuromuscul Disord Mar 2025.
12b Hamid OA, Hester DM, Matesanz SE, Wright S, Batley KY, Proud CM, Veerapandiyan A.: Equitable Access of Delandistrogene Moxeparvovec for Patients With Duchenne Muscular Dystrophy: A Call for Discussion. Pediatr Neurol Oct 2024.
a2 B. Gross, E. Higginbotham, L. Lau, W. Sung, O. Moran, A. Hasnain, D. Stavropoulos, M. Beaulieu Bergeron, K. Boycott, cb V. McNiven, R. Liu, S. Matesanz: Non-tandem duplications in DMD: impacts on genetic counseling and medical decision making. Neuromuscular Disorders 43:104441.484, Oct 2024.
2c
7
1d
1f
Selected Publications
2f0 Wolff JM, Capocci N, Atas E, Bharucha-Goebel DX, Brandsema JF, Butterfield RJ, Chadwick CB, Corti M, Crawford TO, Cripe L, Day JW, Duong T, ElMallah MK, Flanigan KM, George LA, Goedeker NL, Goude E, Hesterlee S, Lin B, Katz NK, Matesanz SE, McDonald C, McNally EM, Mercado-Rodriguez C, Nandi D, Parsons JA, Proud C, Ramos-Platt L, Lek A, Salabarria SM, Camino E, Schrader R, Shea E, Shell R, Shieh PB, Soslow JH, Taylor JB, Veerapandiyan A, Villa C, Yang ML, Zaidman CM, Leon-Astudillo C, Byrne BJ.: Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophy. Neuromuscul Disord 54: 106208, Aug 2025.1fe Byrne BJ, Flanigan KM, Matesanz SE, Finkel RS, Waldrop MA, D'Ambrosio ES, Johnson NE, Smith BK, Bönnemann C, Carrig S, Rossano JW, Greenberg B, Lalaguna L, Lara-Pezzi E, Subramony S, Corti M, Mercado-Rodriguez C, Leon-Astudillo C, Ahrens-Nicklas R, Bharucha-Goebel D, Gao G, Gessler DJ, Hwu WL, Chien YH, Lee NC, Boye SL, Boye SE, George LA.: Current clinical applications of AAV-mediated gene therapy. Mol Ther 33: 2479-2516, Jun 2025.
e2 Fainberg NA, Keselman D, Matesanz SE, Senthil K.: Feeding Difficulties and Respiratory Failure in a 14-Month-Old Girl. Pediatr Rev 46: 337-340, Jun 2025.
11c Wadhwani AR, Aggarwal A, Loscalzao S, McSherry ML, Lockman JL, Brandsema JF, McGuire J, Matesanz S.: Pearls & Oy-sters: Severe Myotonic Crisis Resembling Malignant Hyperthermia. Neurology 104: e213497, Apr 2025.
139 Keselman D, Glanzman A, Thelen MY, Prosser LA, McGuire J, Matesanz SE.: Motor function testing rates and outcomes in Duchenne muscular dystrophy with comorbid autism and attention-deficit/hyperactivity disorder. Neuromuscul Disord Mar 2025.
12b Hamid OA, Hester DM, Matesanz SE, Wright S, Batley KY, Proud CM, Veerapandiyan A.: Equitable Access of Delandistrogene Moxeparvovec for Patients With Duchenne Muscular Dystrophy: A Call for Discussion. Pediatr Neurol Oct 2024.
a2 B. Gross, E. Higginbotham, L. Lau, W. Sung, O. Moran, A. Hasnain, D. Stavropoulos, M. Beaulieu Bergeron, K. Boycott, cb V. McNiven, R. Liu, S. Matesanz: Non-tandem duplications in DMD: impacts on genetic counseling and medical decision making. Neuromuscular Disorders 43:104441.484, Oct 2024.
2c